Patent · US Expired

Human Defensin DEF-X

US6329340A · kind A · utility

7Cited by
2References
56Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 25, 2000
Grant dateDec 11, 2001
Priority date
Expiry dateFeb 25, 2020

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/4721
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a human polypeptide defensin Def-X, homologous to HNP-4, its genomic DNA and cDNA, vectors, cells transformed with said vectors, the use of said polypeptides as antibiotic, cytotoxic, repair and endocrine regulatory agent and as pesticide as well as cosmetic or pharmaceutical compositions for the treatment of microbial infections, in particular bacterial, fungal and viral infections, or parasitic infections, cancers, of inflammation and of immune deficiency. Finally, the invention comprises diagnostic methods and kits for the determination of a microbial or parasitic infection and of an inflammation, or for screening for predisposition to immune deficiencies or cancer diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.